A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from Eli Lilly.

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

From Aug. 1 to the end of the year, Medicaid beneficiaries received 33,035 claims for GLP-1 drugs for weight loss, a number ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Finally, a few studies in mice have found that the medications can reduce the buildup of the protein tau in the brain, which is a key contributor to Alzheimer’s disease. Scaling back tau buildup could ...